Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Non-Current Assets (2017 - 2025)

Catheter Precision (VTAK) has disclosed Non-Current Assets for 9 consecutive years, with $23.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Assets fell 8.09% to $23.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $94.9 million, a 8.3% decrease, with the full-year FY2024 number at $24.5 million, down 7.89% from a year prior.
  • Non-Current Assets was $23.0 million for Q3 2025 at Catheter Precision, down from $23.5 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $35.8 million in Q1 2023 to a low of $1.9 million in Q3 2022.
  • A 5-year average of $18.4 million and a median of $23.9 million in 2025 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: crashed 54.93% in 2022, then soared 1304.61% in 2023.
  • Catheter Precision's Non-Current Assets stood at $4.0 million in 2021, then plummeted by 51.23% to $1.9 million in 2022, then surged by 1277.66% to $26.6 million in 2023, then fell by 7.89% to $24.5 million in 2024, then dropped by 6.01% to $23.0 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Non-Current Assets are $23.0 million (Q3 2025), $23.5 million (Q2 2025), and $23.9 million (Q1 2025).